Trump to Sign Order Tying Drug Costs to Lower Foreign Prices

---

Full Story

President Trump is set to sign an executive order next week linking U.S. government drug payments to lower prices abroad, aiming to reduce medication costs. The move revives a prior effort to address high prescription drug prices. It could reshape how Medicare negotiates drug costs.

The order would tie payments for some drugs to international benchmarks. This targets high U.S. prices compared to other developed nations.

MEDIA REPORTING

See how news sources on all sides are covering this story.

Left 35% | Right 26% | Center 30% | Unrated 9%

The Context

Prescription drug costs have long been a concern for American consumers. Medicare covers millions but faces pressure to lower expenses.

Trump previously attempted similar reforms in 2020. Those efforts stalled amid legal and industry pushback.

The policy would primarily affect drugs under Medicare Part B. These include treatments administered in hospitals or clinics.

Drug pricing varies widely globally due to government regulations. The U.S. often pays significantly more for the same medications.

Some support the plan for making drugs more affordable. Others argue it could limit innovation or access.

The order’s success depends on navigating legal and political hurdles. It could influence broader healthcare reform debates.